Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars

With the development of anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibodies, trastuzumab-based therapy has become the standard of care among patients with early or advanced HER2-positive breast cancer. However, real-world data have shown that up to a half of patients do not re...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Alina Uifălean (Autor), Maria Ilieş (Autor), Raul Nicoară (Autor), Lucia Maria Rus (Autor), Simona Codruţa Hegheş (Autor), Cristina-Adela Iuga (Autor)
Format: Knjiga
Izdano: MDPI AG, 2018-09-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno